XEOMIN Approved for Comprehensive Facial Treatment

This episode explores a key moment in medical aesthetics: the FDA's approval of XEOMIN® (incobotulinumtoxinA) for the simultaneous treatment of forehead lines, frown lines, and crow's feet. Initially approved in 2011 for frown lines, XEOMIN® now expands its scope, offering a comprehensive solution for upper facial lines. Hear from Merz Aesthetics' Chief Scientific Officer, Dr. Samantha Kerr, and President of North America, Patrick Urban, about the product's unique formulation and the technolo...